<DOC>
	<DOCNO>NCT02151591</DOCNO>
	<brief_summary>The purpose study develop test integrate cognitive-behavioral intervention smoking alcohol among heavy drinking smoker . The current pre-pilot phase use refine protocol subsequent randomize , control pilot phase . The current study phase two part : 1 ) intake session brief physical ; 2 ) 12-week treatment phase participant receive varenicline ( Chantix ) weekly , personalize counseling .</brief_summary>
	<brief_title>New Approaches Smoking Cessation Heavy Drinkers</brief_title>
	<detailed_description>The purpose propose project develop test 12-week integrated cognitive-behavioral therapy ( CBT ) intervention smoke alcohol ( SA ) + varenicline ( Chantix ) among heavy drinking smoker ( i.e. , CBT SA ) . The project involve two phase . In Phase 1 , open-label pre-pilot study CBT SA conduct 10 heavy drinking smoker . The primary result phase use refine CBT SA protocol . In Phase 2 , randomize , control pilot study conduct 40 heavy drinking smoker compare CBT SA standard smoke counseling ( SC ) . All participant randomize pilot study also receive varenicline ( Chantix ) . Primary Study Completion date change 6/2016 reflect additional year add year study .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Alcoholic Intoxication</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1. least 18 year age ; 2. report smoke 100 cigarette lifetime currently smoke least twice weekly average past 90 day urinary cotinine level &gt; =30ng/mL semiquantitative analysis , and/or &gt; = 2 NicAlert dipstick 3. interested quit smoking ; 4. understand English ; 5. exceed National Institute Alcohol Abuse Alcoholism heavy drinking criterion ( i.e. , men , &gt; 14 drinks/week 5 drinks/day least per month past 12 month ; woman , &gt; 7 drinks/week &gt; 4 drinks/day least per month past 12 month . 1. meet criterion alcohol dependence past 12 month clinically severe define history seizure , delirium , hallucination alcohol withdrawal ; Clinical Institute Withdrawal Assessment scale ( Sullivan et al. , 1989 ) score &gt; 8 ; report drink avoid withdrawal symptom , ) prior treatment withdrawal ; require medical treatment alcohol withdrawal within past 6 month ; 2. currently enrol alcohol treatment ; 3. meet criterion drug dependence past 12 month ; exception marijuana dependence 4. exhibit serious psychiatric illness ( i.e. , schizophrenia , bipolar disorder , severe major depression , panic disorder , borderline personality disorder , organic mood mental disorder history psychological examination ; 5. report current suicidality ( past 12 month ) , report suicide attempt within past 10 year , assess Columbia Suicide Severity Rating Scale ; 6. exhibit current , clinically significant physical disease abnormality base medical history , physical examination , routine laboratory evaluation include : unexplained elevation liver enzymes ( i.e. , transaminase , bilirubin ) ; clinically significant , unstable cardiovascular disease/uncontrolled hypertension ; hepatic renal impairment ; severe obstructive pulmonary disease ; diabetes mellitus require insulin certain oral medication ( i.e. , sulfonylurea ) A1C hemoglobin test score &gt; 7 participant prescribed medication ; baseline systolic blood pressure high 150 mm Hg diastolic blood pressure high 95 mm Hg ; 7. cognitively impaired ; 8. unable read/understand English ; 9. female childbearing potential pregnant , nursing , practice effective contraception ( oral , injectable , implantable contraceptive , intrauterine device , barrier method spermicide ) ; 10. report new onset psychiatric disorder new psychotropic medication within past 3 month , except individual stable dose Selective Serotonin Reuptake Inhibitor least two month report occasional use prescription sleep aid willing discontinue ; 11. use another investigational drug within 30 day use medication treat alcohol ( e.g. , naltrexone , topiramate , acamprosate , disulfiram ) nicotine use ( e.g. , clonidine , varenicline , bupropion , nicotine replacement ) past 3 month intend use medication ; ( prior use nicotine replacement situation smoke permit ( e.g. , plane ) without intention quit smoking exclusionary screening ) 12. intend donate blood blood product treatment phase study ; 13. history cancer ( except treat basal cell squamous cell carcinoma skin ) ; 14. history serious hypersensitivity reaction skin reaction varenicline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Quit smoking</keyword>
	<keyword>Quit drinking</keyword>
</DOC>